MBX Biosciences, Inc. (MBX) News
Follow MBX Biosciences, Inc. (MBX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Microbix Presenting at Muskoka Capital Event
Meetings with Growth-Oriented Investors, September 25 to 27, 2026MISSISSAUGA, ON / / September 23, 2026 / Microbix Biosystems Inc. TSX:MBXOTC:MBXBF(Microbix®), a life sciences innovator, manufacturer, and exporter, annou
NEWS | Sep 23, 2026, 11:01 AM UTC
L
MBX Biosciences to take part in upcoming investor conferences
MBX Biosciences says it will participate in upcoming investor conferences. The company is a clinical-stage biopharmaceutical focused on precision peptide therapies for endocrine and metabolic disorders.
EQUITY | Sep 09, 2026, 12:01 PM UTC
L
Microbix completes supplier qualification for five IVD product lines
Microbix Biosystems Inc. says it has completed formal qualification to become a supplier for five in-vitro diagnostics manufacturers’ product lines, supporting leading IVD manufacturers.
EQUITY | Sep 09, 2026, 11:01 AM UTC
L
MBX Biosciences appoints Jeff Held as Chief Legal Officer
MBX Biosciences announced the appointment of Jeff Held as Chief Legal Officer.
EQUITY | Sep 08, 2026, 12:00 PM UTC
L
MBX Biosciences doses first patient in Phase 3 oPTimize trial
MBX Biosciences has dosed the first patient in its Phase 3 oPTimize trial of once-weekly canvuparatide.
EQUITY | Aug 27, 2026, 12:43 PM UTC
M
MBX Biosciences first patient dosed in Phase 3 oPTimize trial
MBX Biosciences announced first patient dosed in its pivotal Phase 3 oPTimize trial of once-weekly canvuparatide for adults with hypoparathyroidism.
EQUITY | Aug 27, 2026, 12:07 PM UTC
L
MBX - MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
MBX - MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
EARNINGS | Aug 06, 2026, 12:01 PM UTC
H
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Nasdaq Composite falling around 400 points on Friday. Shares of ManpowerGroup Inc (NYSE: MAN ) rose sharply after the company reported upbeat second-quarter results and issued third-quart
EARNINGS | Jul 17, 2026, 02:09 PM UTC
H
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
Fast-unraveling ceasefire between Iran and U.S. amid continued dispute over the control of transit through the Strait of Hormuz has reverberated across the asset classes in a predictable fashion on Monday. WTI Crude Oil
CENTRAL_BANK | Jul 13, 2026, 11:42 PM UTC